4-(3-chloroanilino)quinazoline has been researched along with Metabolic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbosa, J; Baugh, SD; Coulter, E; Desai, U; Gay, JP; Gopinathan, S; Han, Q; Hari, R; Kimball, SD; Lombardo, VK; Nguyen, HV; Ni, CY; Pabba, PK; Powell, DR; Smith, A; Terranova, KM; Wilson, A; Yu, XC | 1 |
1 other study(ies) available for 4-(3-chloroanilino)quinazoline and Metabolic Syndrome
Article | Year |
---|---|
Design, synthesis, and in vivo activity of novel inhibitors of delta-5 desaturase for the treatment of metabolic syndrome.
Topics: Amides; Animals; Delta-5 Fatty Acid Desaturase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Fatty Acid Desaturases; Humans; Liver; Metabolic Syndrome; Mice; Molecular Structure; Structure-Activity Relationship | 2015 |